Inactive Instrument
Quotes StemCells Inc Nasdaq
Stocks
US85857R2040
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 11-05 | Microbot Medical Adds Canadian Patent to IP Portfolio | MT |
| 10-27 | Microbot Medical Inc. Announces ELMNT IR as First Office-Based Lab Customer for LIBERTY Endovascular Robotic System | CI |
Stock exchange
Basic data
Market Cap (USD)
74,552,929
Net sales (USD)
0
Free-Float
100%
Free-Float capitalization (USD)
74,552,929
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 74.55M | |
| -4.83% | +3.51% | +55.00% | +63.79% | 65.94B | |
| +0.02% | +1.07% | +11.72% | +75.63% | 56.88B | |
| -1.34% | +2.98% | +25.08% | +100.18% | 56.53B | |
| +5.09% | +9.89% | +27.19% | +105.85% | 46.49B | |
| +2.62% | +1.68% | +29.16% | +35.86% | 44.8B | |
| +8.24% | +0.51% | +215.16% | +794.74% | 41.59B | |
| -1.86% | +10.13% | +28.14% | +55.48% | 35.35B | |
| -2.97% | -9.84% | +90.91% | +73.49% | 33.29B | |
| +5.19% | +1.62% | -39.69% | +368.87% | 25.1B | |
| Average | +1.13% | +2.65% | +49.18% | +185.99% | 40.6B | |
| Weighted average by Cap. | +0.66% | +3.07% | +49.89% | +166.07% |
Historical Quotes: StemCells Inc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- MBOT Stock
- Stock
- Quotes StemCells Inc
Select your edition
All financial news and data tailored to specific country editions
